Endothelial Dysfunction during The COVID-19 follow-up: TUN-EndCOV study

Not Applicable

Recruiting

• Conditions: Respiratory; Circulatory System; Cardiology

• Registration Number: PACTR202102867544936

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-02-03
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

•age >18 years, both sexes;
•written informed consent;
•a recent diagnosis of COVID19 (1 - 6 months) proven by RT-PCR or viral rapid test.

Exclusion Criteria

•Age <18 years
•Inability to express consent of the study
•Diseases carrying out a life -expectancy <1 year according to clinical judgment
•Pregnancy and breastfeeding
•Foreseen inability to attend scheduled visits

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The evaluation of microvascular reactivity in post COVID-19 patients with DTM at 21-days follow-up.

Secondary Outcome Measures

Name	Time	Method
The CV events – mortality 1, 3 and 12 months after patient’s inclusion. <br>The predefined secondary outcome was a new cardiovascular event. Patients were followed for the development of cardiovascular disease, defined as death, an acute coronary syndrome, a cerebrovascular event, pulmonary embolism or deep venous thrombosis or hospitalizations due to cardiac events.<br>